We are live on ! Find out more
GCM

Graham Capital Management Portfolio holdings

AUM $4.14B
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
+17.82%
3 Year Est. Return
+41.13%
5 Year Est. Return
+43.39%
10 Year Est. Return
+274.46%
AUM
$5.81B
AUM Growth
+$1.21B
Cap. Flow
-$111M
Cap. Flow %
-1.92%
Top 10 Hldgs %
50.93%
Holding
1,403
New
403
Increased
294
Reduced
341
Closed
336

Top Sells

Rank Stock Value
1
MSTR icon
Strategy Inc
MSTR
+$59.8M
2
KO icon
Coca-Cola
KO
+$16M
3
STT icon
State Street
STT
+$14M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CMS icon
CMS Energy
CMS
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 5.72%
2 Industrials 4.29%
3 Financials 3.7%
4 Consumer Discretionary 2.83%
5 Healthcare 2.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KOPN icon
1026
Kopin
KOPN
$791M
$44K ﹤0.01%
60,215
-12,664
-17% -$11.6K
SES icon
1027
SES AI
SES
$208M
$41.7K ﹤0.01%
65,101
+32,368
+99% +$33.8K
RVNC
1028
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
$41.5K ﹤0.01%
+8,000
New +$39.8K
CLNE icon
1029
Clean Energy Fuels
CLNE
$346M
$41.4K ﹤0.01%
+13,311
New +$37.7K
GSAT icon
1030
Globalstar
GSAT
$10.8B
$37K ﹤0.01%
+1,991
New +$36.8K
NNDM
1031
Nano Dimension
NNDM
$343M
$33.9K ﹤0.01%
+13,817
New +$31.1K
KOD icon
1032
Kodiak Sciences
KOD
$2.84B
$32.2K ﹤0.01%
12,354
-17,328
-58% -$46.1K
ACET icon
1033
Adicet Bio
ACET
$74.7M
$31K ﹤0.01%
1,344
-2,105
-61% -$47.1K
LWLG icon
1034
Lightwave Logic
LWLG
$1.25B
$28.9K ﹤0.01%
+10,464
New +$31.4K
BBD icon
1035
Banco Bradesco
BBD
$36.7B
$28K ﹤0.01%
+10,514
New +$26.9K
TNYA icon
1036
Tenaya Therapeutics
TNYA
$163M
$26.9K ﹤0.01%
13,962
-2,265
-14% -$6.39K
NKTR icon
1037
Nektar Therapeutics
NKTR
$2.58B
$24.8K ﹤0.01%
1,270
-553
-30% -$10.5K
IVVD icon
1038
Invivyd
IVVD
$218M
$24.4K ﹤0.01%
23,884
-35,585
-60% -$38.6K
URG
1039
Ur-Energy
URG
$556M
$24.2K ﹤0.01%
+20,303
New +$24.3K
EVC icon
1040
Entravision Communication
EVC
$1.1B
$22.5K ﹤0.01%
10,851
+82
+0.8% +$164
POWW icon
1041
Outdoor Holding Co
POWW
$247M
$18.1K ﹤0.01%
+12,631
New +$20K
VXRT
1042
DELISTED
Vaxart
VXRT
$17.7K ﹤0.01%
+20,849
New +$15.9K
SPCE icon
1043
Virgin Galactic
SPCE
$398M
$17.6K ﹤0.01%
+2,880
New +$19.2K
GPRO icon
1044
GoPro
GPRO
$126M
$14.7K ﹤0.01%
+10,835
New +$14.9K
ADAP
1045
DELISTED
Adaptimmune Therapeutics
ADAP
$12K ﹤0.01%
+12,592
New +$14.3K
AAT
1046
American Assets Trust
AAT
$1.4B
-15,132
Closed -$339K
ABCB icon
1047
Ameris Bancorp
ABCB
$5.89B
-5,791
Closed -$292K
ABNB icon
1048
Airbnb
ABNB
$107B
-15,898
Closed -$2.41M
ADMA icon
1049
ADMA Biologics
ADMA
$2.22B
-13,544
Closed -$151K
ADVM
1050
DELISTED
Adverum Biotechnologies
ADVM
-11,782
Closed -$80.8K

Similar funds

Graham Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Graham Capital Management held 1,403 positions worth $5.81B, up 26% from $4.6B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Graham Capital Management's Q3 2024 filing shows 403 new, 294 increased, 341 reduced and 336 closed positions. Its largest new stake was VanEck Gold Miners ETF: 554,036 shares worth $22.1M. The largest sale was Strategy Inc, an estimated $59.8M.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, down from 6.7% a quarter earlier, followed by Industrials and Financials.

  • Graham Capital Management's largest Q3 2024 buy was VanEck Gold Miners ETF: 554,036 shares worth $22.1M.
  • Graham Capital Management added most to iShares Bitcoin Trust in Q3 2024, an estimated $37.1M increase.
  • Graham Capital Management's biggest Q3 2024 reduction was State Street, cutting an estimated $14M.
  • Graham Capital Management fully exited Strategy Inc in Q3 2024, selling an estimated $59.8M.
  • Graham Capital Management's ten largest holdings make up 51% of its $5.81B portfolio in Q3 2024.
  • Graham Capital Management opened 403 new positions and closed 336 in Q3 2024.
  • Graham Capital Management's portfolio value rose 26% quarter-over-quarter to $5.81B.

Based on Graham Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.